Latest AI and machine learning research in other cancers for healthcare professionals.
Deep learning (DL) is increasingly applied to automate brain tumor classification from magnetic resonance imaging (MRI), yet meaningful clinical deployment remains limited by tumor heterogeneity, dataset bias, and incomplete tumor-specific validation. This systematic review synthesizes developments from 2016 to 2025 in advanced DL-based MRI brain tumor classification, with a specific emphasis on m...
Microvascular invasion (MVI) represents a critical prognostic determinant in hepatocellular carcinoma (HCC), yet preoperative prediction remains challenging. MRI-based radiomics offers promise for noninvasive MVI stratification through quantitative feature extraction from intratumoral and peritumoral regions, with growing interest in integrating both compartments to capture tumor-host interactions...
PURPOSE: Among the extraintestinal ocular manifestations of patients with inflammatory bowel disease (IBD), episcleritis is associated with the inflam...
BACKGROUND: Intraoperative ultrasound plays a central role in hepatobiliary surgery for the detection of liver lesions, but image interpretation is ch...
OBJECTIVES: This study aims to develop a predictive model that combines MRI radiomics features with clinical factors to anticipate the preoperative pr...
BACKGROUND: Lung adenocarcinoma (LUAD) remains a prevalent malignant tumor characterized by a dismal prognosis. This study aimed to reveal potential m...
BACKGROUND: Accurate identification of sentinel lymph node (SLN) status is essential for surgical and adjuvant therapy decisions in breast cancer. Alt...
OBJECTIVE: This review systematically evaluates the current research landscape, methodological characteristics, and translational challenges of artifi...
The TGF-β signaling pathway plays a dual role in cancer, acting as both a tumor suppressor and a potent driver of metastasis and immune evasion. Tradi...
BACKGROUND AND PURPOSE: While intravesical Bacillus Calmette-Guérin Vaccine (BCG) instillation remains standard adjuvant therapy for high-grade non-mu...
BACKGROUND: KRAS-mutant lung adenocarcinoma (LUAD) is associated with aggressive phenotypes and therapy resistance, which highlights an urgent need to...
Among various types of cancers, lung cancer causes the highest mortality globally, necessitating prompt diagnosis for effective treatment. Traditional...
Brain metastasis remains a major clinical challenge because intracranial progression and therapeutic resistance arise not only from tumour-intrinsic p...
BACKGROUND: Neoantigens-tumor-specific peptides generated by somatic mutations-are central targets of effective anticancer T cell immunity and underpi...
Human epidermal growth factor receptor 2 (HER2)-targeted therapies have revolutionized breast cancer treatment, necessitating standardized HER2 testin...
Sialylated alpha-fetoprotein (sAFP) is a very potential marker for the pathogenesis exploration and clinical assessment of hepatocellular carcinoma (H...
Tumor vasculature has traditionally been viewed as structurally and functionally abnormal and, therefore, is primarily targeted for inhibition. Howeve...
Brain tumors remain among the most lethal cancers, largely due to their remarkable heterogeneity, plasticity, and resistance to therapy. The second Br...
BACKGROUNDS: Breast cancer (BRCA) represents the most prevalent malignancy globally, with projections indicating 3.2 million new cases anticipated by ...
BACKGROUND: Diffuse gliomas remain among the most surgically challenging tumors, characterized by their infiltrative nature, proximity to eloquent bra...